What is ACRV stock price today?

Visit our real-time dashboard for the current ACRV stock price and live market data.

Is ACRV stock going up or down today?

ACRV stock price movements are influenced by market conditions, news, earnings reports, and investor sentiment. Check our live dashboard for real-time price changes and technical indicators.

Should I buy ACRV stock now?

The decision to buy ACRV depends on your investment strategy, risk tolerance, and financial goals. Our AI analysis evaluates fundamentals, valuation metrics, growth prospects, and market conditions to help inform your decision.

Is ACRV a buy, hold, or sell right now?

Our AI-powered analysis provides buy/hold/sell recommendations for ACRV based on multiple factors including valuation, growth metrics, technical indicators, and analyst consensus. Visit our dashboard for the latest recommendation.

Is ACRV stock overvalued or undervalued?

Use our DCF valuation calculator to determine if ACRV is overvalued or undervalued based on fundamental analysis and future cash flow projections.

What is ACRV's P/E ratio?

P/E ratio data for ACRV will be available after the company reports earnings. Visit our dashboard for the latest financial metrics.

What is ACRV's market cap?

ACRV (Acrivon Therapeutics, Inc. Common Stock) has a market capitalization of $0.07 billion, making it a small-cap stock.

What is ACRV's price to book ratio?

ACRV trades at a price-to-book (P/B) ratio of 0.68, which compares the stock price to the company's book value per share. A P/B below 1.0 may indicate undervaluation, while above 3.0 may suggest premium pricing.

Does ACRV pay dividends?

ACRV does not currently pay dividends. Many growth companies reinvest profits into the business rather than paying dividends.

What is ACRV's dividend yield?

ACRV does not currently pay dividends or dividend data is not available. Check our dashboard for the latest information.

Is ACRV stock a good long-term investment?

ACRV's long-term investment potential depends on sustainable competitive advantages, revenue growth, profitability, management quality, and industry dynamics. Our AI analysis evaluates these factors to assess long-term prospects.

What is ACRV's revenue growth rate?

Revenue growth data for ACRV is available on our dashboard with detailed financial statement analysis.

Profitability metrics for ACRV are available on our dashboard with complete income statement analysis.

What are the risks of investing in ACRV?

Key risks for ACRV include market volatility, competitive pressures, regulatory changes, economic conditions, execution risks, and company-specific factors. Our AI analysis identifies material risks and their potential impact on valuation.

How does ACRV compare to its competitors?

Compare ACRV to industry peers on our dashboard using metrics like P/E ratio, revenue growth, profit margins, market share, and valuation multiples. Competitive analysis helps contextualize ACRV's performance and positioning.

What is ACRV's stock price target for 2026?

Visit our prediction page for AI-powered price targets for ACRV with bull, base, and bear case scenarios.

What do analysts say about ACRV?

Wall Street analysts provide ratings (buy/hold/sell) and price targets for ACRV. Our dashboard aggregates analyst consensus, target prices, and recent upgrades/downgrades to help you understand professional sentiment.

When is ACRV's next earnings report?

ACRV reports earnings quarterly. Check our dashboard for the upcoming earnings date, analyst estimates for revenue and EPS, and historical earnings performance. Earnings reports often drive significant stock price movements.

ACRV - Acrivon Therapeutics, Inc. Common Stock

NYSE * Healthcare * Biotechnology

$0.00

+$0.00 (+0.00%)

About Acrivon Therapeutics, Inc. Common Stock

Acrivon Therapeutics, Inc. Common Stock (ACRV) common stock

Price Chart

Loading chart...

ACRV Key Statistics

Market Cap

$65.06M

P/B Ratio

0.68

How ACRV Compares to Peers

ACRV is the smallest among peers, which may offer higher growth potential

P/E Rank

N/A

of 5

Margin Rank

N/A

of 0

Growth Rank

N/A

of 0

Size Rank

of 6

Company	Market Cap	P/E	Growth	Margin	Compare
ACRV(This stock)	$65.06M	N/A	0%	0.0%	-
AMGNAmgen Inc	$188.67B	24.3	0%	0.0%	vs AMGN
GILDGilead Sciences	$160.15B	17.5	0%	0.0%	vs GILD
VRTXVertex Pharmaceuticals	$106.87B	29.7	0%	0.0%	vs VRTX
REGNRegeneron Pharmaceuticals	$59.10B	13.9	0%	0.0%	vs REGN
BIIBBiogen Inc	$29.33B	21.4	0%	0.0%	vs BIIB

Data Updated: July 23, 2026 at 6:06 PM EDT

Ready to invest in ACRV?

Commission-free trading available. Affiliate links.

ACRV Lician Score

5% confidence

4.0/10

Neutral

ACRV has a Lician Score of 4/10 (Average). Areas of concern: Growth.

value

5.0

growth

2.0

quality

5.0

momentum

5.0

safety

5.0

The Lician Score is a comprehensive 1-10 rating that evaluates ACRVacross five key dimensions: Value (valuation relative to sector),Growth (revenue and earnings trajectory),Quality (profitability and balance sheet strength),Momentum (price trends and analyst sentiment), andSafety (volatility and risk metrics).

ACRV Financial Snowflake

5-axis analysis across key investment dimensions

4.4/10

Neutral

5.0

Value

Valuation vs. sector peers

2.0

Growth

Revenue & earnings trajectory

5.0

Quality

Profitability & moat strength

5.0

Momentum

Price trends & analyst sentiment

5.0

Safety

Financial stability & risk

Upcoming Events for ACRV

Dashboard

Enter a ticker to analyze